Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9 GBX | -10.00% | -25.00% | -59.09% |
19/04 | Redx Pharma shareholders approve AIM delisting plans | AN |
19/04 | Redx Pharma Gets Shareholder Approval for Delisting from AIM | MT |
Sales 2024 * | 12.5M 15.61M 1.3B | Sales 2025 * | - | Capitalization | 35.01M 43.73M 3.65B |
---|---|---|---|---|---|
Net income 2024 * | -26M -32.48M -2.71B | Net income 2025 * | -49M -61.21M -5.1B | EV / Sales 2024 * | 2.42 x |
Net cash position 2024 * | 4.81M 6.01M 501M | Net Debt 2025 * | 39.12M 48.87M 4.07B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.34
x | P/E ratio 2025 * |
-0.71
x | Employees | 101 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.72% |
Latest transcript on Redx Pharma Plc
1 day | -10.00% | ||
1 week | -25.00% | ||
Current month | -51.35% | ||
1 month | -52.00% | ||
3 months | -56.10% | ||
6 months | -65.38% | ||
Current year | -59.09% |
Managers | Title | Age | Since |
---|---|---|---|
Lisa Anson
CEO | Chief Executive Officer | - | 01/18/01 |
Peter J. Collum
DFI | Director of Finance/CFO | - | 05/21/05 |
Chief Operating Officer | 46 | 19/18/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 27/22/27 |
Joseph Anderson
BRD | Director/Board Member | 65 | 06/23/06 |
Peter Presland
BRD | Director/Board Member | 75 | 03/17/03 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 9 | -10.00% | 670,146 |
25/24/25 | 10 | +8.11% | 469,403 |
24/24/24 | 9.25 | -9.76% | 164,204 |
23/24/23 | 10.25 | -16.33% | 277,553 |
22/24/22 | 12.25 | +2.08% | 265,344 |
Delayed Quote London S.E., April 26, 2024 at 09:05 pm IST
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-59.09% | 43.61M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- REDX Stock